Organization
Organizaciόn Medica de Investigaciόn, Buenos Aires, Argentina
1 abstract
Abstract
A PHASE IIB STUDY OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL ANTIBODY) WITH OR WITHOUT METHOTREXATE IN ADULTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE Org: Brigham and Women's Hospital, Boston, MA, Swedish Medical Center and University of Washington, Seattle, United States, Organizaciόn Medica de Investigaciόn, Buenos Aires, Argentina, Keio University, Tokyo, Japan, Csolnoky Ferenc Hospital, Veszprém, Hungary,